000 | 04984cam a2200577 i 4500 | ||
---|---|---|---|
001 | ocn829236612 | ||
003 | OCoLC | ||
005 | 20221128212141.0 | ||
006 | m d | ||
007 | cr ||||||||||| | ||
008 | 120503t20122012nyua ob 001 0 eng | ||
010 | _a 2020686181 | ||
040 |
_aDLC _beng _erda _cDLC _dYDXCP _dE7B _dOCLCF _dEBLCP _dAU@ _dSTF _dN$T |
||
020 |
_a9781622570560 _qebook |
||
020 | _a1622570561 | ||
020 |
_z9781622570423 _qhardcover |
||
020 | _z1622570421 | ||
035 |
_a535131 _b(N$T) |
||
035 | _a(OCoLC)829236612 | ||
042 | _apcc | ||
072 | 7 |
_aHEA _x039110 _2bisacsh |
|
072 | 7 |
_aMED _x056000 _2bisacsh |
|
049 | _aMAIN | ||
245 | 0 | 0 |
_aNeurological disorders : _bnew research _c _h[E-Book] |
264 | 1 |
_aNew York : _bNova Biomedical, Science Science Publishers, Incorporated, _c[2012] |
|
300 | _a1 online resource. | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 0 | _aNeuroscience research process | |
490 | 0 | _aNeurology--laboratory and clinical research developments | |
504 | _aIncludes bibliographical references and index. | ||
588 | _aDescription based on print version record and cip data provided by publisher. | ||
505 | 0 | _aNEUROLOGICAL DISORDERS ; NEUROLOGICAL DISORDERS ; Contents; Preface; Advanced Structural and Functional MRI Techniques in Parkinson's Disease; Abstract; Introduction; MR Morphometry; Diffusion MR Imaging; Functional MRI; Motor fMRI; Cognitive fMRI; Resting-State fMRI; Conclusion; References; Neuropoietic Cytokines and Neural Injury: Alterations in JAK2/STAT3 Signaling Associated with Aging; Abstract; 1. Introduction; 1.1. Neuropoietic Cytokine Family; 1.2. Role of the gp130 Cytokine Receptor Complex; 1.3. Role of Janus Kinases (Jaks) | |
505 | 8 | _a1.4. Activation of Signal Transducer and Activator of Transcription 3 (STAT3)1.5. Effects of Phospho-STAT3 (pSTAT3); Cell Survival; Remodeling the Cellular Environment; Regulating Oxidative Stress; Immune Tolerance; Role of the Phosphorylation Site; 1.6. Regulating pSTAT3: Role of Negative Regulators; Suppressors of Cytokine Signaling (SOCS); Protein Inhibitors of Activated Stats (PIAS); Protein Tyrosine Phosphatases (PTP); 2. Discussion; 2.1. Changes in Neural Injury; Stroke; Traumatic Brain Injury; 2.2. JAK2/STAT3 Regulation Altered with Aging; 2.3. Significance of Phosphorylation Site. | |
505 | 8 | _a3. Future Directions3.1. Elucidate the Role of STAT3 across Cell Types; 3.2. Modulating Beneficial vs. Detrimental Effects; 3.3. Identifying Injury-Associated Changes; 3.4. Understanding and Manipulating Regulatory Processes for Therapeutic Benefit; 3.5. The IL-6 and IL-10 Signaling Dynamic; 3.6. Therapeutic Development: Challenges of Inhibition; Conclusion; Acknowledgments; References; Neurological Complications Associated with Anti-Tumor Necrosis Factor Alpha (TNF-<U+0041>) Treatment; Abstract; Introduction; Tumor Necrosis Factor (TNF)-<U+0041>; Pathogenicity of TNF-<U+0041> in Neurological Disorder. | |
505 | 8 | _aAnti-TNF-<U+0041> or TNF-<U+0041> Antagonist DrugAnti-TNF-<U+0041> and Neurological Disorders; Conclusion; References; Effect of Aging on Changes of Nociception and Cav2 1 Expression Patterns in Seven Inbred Mouse Strains; Abstract; Introduction; Materials and Methods; Animals; Nociceptive Assays; Statistical Analysis of Behavioral Tests; Real-Time qRT-PCR Analysis; Results; Pain-Related Behavioral Tests; Expression Tests of Cav2 Family Members with Real-Time qRT-PCR Assay; Discussion; Conclusion; Acknowledgments; References; Polymeric Intracorporeal Devices for the Management of Neurological Disorders. | |
505 | 8 | _aAbstract1. Introduction; 2. Polymer-Based Implantable Devices for Major CNS Disorders; 2.1. Intracranial Implants; 2.1.1. Drug Delivery Approaches Employed to Traverse the Blood Brain Barrier; 2.1.1.1. Ethylene Vinyl Acetate Copolymers Avac as a Prototype; Biocompatible Polymer Employed for Local Drug Delivery to the Brain; 2.1.1.2. Silk-Based Polymers as an Alternative to Synthetic Drug Delivery-Systems for the Treatment of Epilepsy; 2.1.2. Application of Polymer-Based Implantable Devices in Parkinson's Disease; 2.1.2.1. Biocompatible Dopamine-Loaded Polymeric Matrix Device. | |
590 | _aMaster record variable field(s) change: 050, 082 | ||
650 | 0 |
_aNervous system _xDiseases. |
|
650 | 0 | _aNeurology. | |
700 | 1 |
_aThomas, Chloe E., _eeditor of compilation. |
|
700 | 1 |
_aMoore, Jayden R., _eeditor of compilation. |
|
856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=535131 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
938 |
_aYBP Library Services _bYANK _n10251442 |
||
938 |
_aEBSCOhost _bEBSC _n535131 |
||
938 |
_aebrary _bEBRY _nebr10683149 |
||
938 |
_aProQuest Ebook Central _bEBLB _nEBL3021491 |
||
942 | _n0 | ||
994 |
_a92 _bN$T |
||
999 |
_c90993 _d90993 |